Baseline and CRHstimulated ACTH and cortisol levels after administration of the PPAR-g ligand, rosiglitazone, in Cushing's disease. - Cannavo,S.; Ambrosi,B.; Chiodini,I.; Vigo,T.; Russo,A.; Milici,C.; Barbetta,L.; Dall'Asta,C.; Adda,G.; Arosio,M. (J End Invest, 2004)